Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, BRASILEIROS, EXPRESSÃO GÊNICA, LIPÍDEOS (TERAPIA), HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 233, n. 1, p. 206-210, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.028. Acesso em: 08 maio 2024.APA
Santos, P. C. J. L., Morgan, A. C., Jannes, C. E., Turolla, L., Krieger, J. E., Santos, R. D., & Pereira, A. C. (2014). Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 233( 1), 206-210. doi:10.1016/j.atherosclerosis.2013.12.028NLM
Santos PCJL, Morgan AC, Jannes CE, Turolla L, Krieger JE, Santos RD, Pereira AC. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2014 ; 233( 1): 206-210.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.028Vancouver
Santos PCJL, Morgan AC, Jannes CE, Turolla L, Krieger JE, Santos RD, Pereira AC. Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2014 ; 233( 1): 206-210.[citado 2024 maio 08 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.028